(b)(4).This report is being submitted due to a retrospective review conducted under capa (b)(4).Device by manufacturer: on 3-dec-2015, an fse was dispatched to the customer facility to address the reported event.Fse began to troubleshoot the issue.Fse verified the issue and replaced rotor seal and stator face, 6-way valve seal, and small syringe.Fse verified proper operation.The customer ran quality control (qc) in which all results were within acceptable range and verified that the analyzer was functioning correctly.The g8 analyzer was functioning as intended and the errors cleared.No further action required by field service.The probable cause of the event was rotor seal and stator face seal.
|
On (b)(6) 2015, a customer reported low ta on br qc, always on first diluted sample run, cc=2234 with their g8 analyzer.Using liquid br control, went over how control is made up.Controls opened on (b)(6) 2015, total area was low on l1, customer added more control to the cup and "it worked".Asked customer to use 10 ul and add 2 mls of fresh h and w.Using tosoh cups in rack and using bc adapter, went over how high cup is sitting in rack.Followup, l1 ta=430, l2=845.Thawing new qc1 now, will repeat test.Followup, customer changed the order that was run in, ran l2 first, then l1.Now l2 has a low ta, l1 ran ok on the newly made vial.Customer moved the controls deeper into the rack, seems like whatever is in the first sampling position ends up with a low ta (when run as a diluted sample).Whole bloods run after qc, all have acceptable tas even the first sample run.Cc=2234.The customer is unable to run hba1c patient samples.A field service engineer (fse) was dispatched to address the reported event, which resulted in delayed reporting hba1c patient results.There was no indication of patient intervention or adverse health consequences due to the delay in reporting.
|